Medical Director, Enfortumab Vedotin

About this role

ROLE SUMMARY The Medical Director will serve as a physician within the Enfortumab vedotin Oncology Late Development team, contributing to the development and execution of clinical strategies that advance transformative therapies for patients with cancer.   This role combines study-level clinical leadership with broader strategic contributions across the asset lifecycle. Working in close partnership with Clinical Scientists, Worldwide Medical, Translational Oncology, Biostatistics, Safety, Regulatory, and other cross-functional stakeholders, the Medical Director will help generate evidence that addresses both regulatory requirements and the evolving needs of patients, healthcare providers, and healthcare systems.   The successful candidate will bring strong scientific and clinical judgment, an interest in strategic drug development, and a collaborative mindset. This individual will be expected to leverage emerging technologies, including AI-enabled tools and advanced analytics, to enhance decision-making, accelerate insights generation, and improve operational efficiency.

ROLE RESPONSIBILITIES Clinical Development Leadership • Provide clinical leadership for clinical study teams, ensuring scientific rigor, patient focus, and alignment with program objectives. • Partner closely with Clinical Scientists and cross-functional colleagues to deliver high-quality study execution and data generation. • Conduct medical monitoring activities, including eligibility review, safety surveillance, data review, and clinical issue management. • Lead peer-to-peer scientific engagement with investigators and key external experts. • Serve as the clinical point of contact for investigators, ethics committees, steering committees, and regulatory authorities. • Contribute to the design, development, and maintenance of clinical protocols, amendments, clinical study reports, investigator materials, and regulatory documentation.

Strategic Development & Evidence Generation • Contribute to the development of clinical and evidence-generation strategies that support both regulatory objectives and broader patient and healthcare stakeholder needs. • Apply evolving understanding of the oncology landscape, standard of care, and competitive environment to inform development decisions and study planning. • Collaborate with Worldwide Medical and cross-functional partners to ensure alignment of evidence generation priorities throughout the product lifecycle. • Support identification of opportunities to optimize development programs through innovative trial design, external insights, and emerging scientific advancements.

Data Interpretation & Insight Generation • Partner with Clinical Scientists and quantitative functions to review, interpret, and communicate clinical data and emerging evidence. • Translate complex clinical findings into actionable insights that guide program-level decisions and future development plans. • Utilize advanced analytics and AI-enabled tools to enhance data synthesis, knowledge generation, and operational efficiency. • Contribute to scientific communications, publications, congress presentations, and internal governance discussions as appropriate.

Collaboration & External Engagement • Foster strong partnerships across Clinical Development, Worldwide Medical, Safety, Regulatory, Biometrics, Translational Sciences, and Commercial colleagues as appropriate. • Maintain awareness of emerging scientific, clinical, and healthcare trends relevant to the therapeutic area. • Engage with external experts, investigators, and scientific communities to gather insights that inform development strategy. • Promote a culture of innovation, continuous learning, and patient-centered drug development.

BASIC QUALIFICATIONS • MD, DO, or equivalent medical degree. • 2-5 years of pharmaceutical, biotechnology, academic research, or clinical development experience. • Demonstrated understanding of clinical research methodology and drug development. • Strong scientific communication and cross-functional collaboration skills.

PREFERRED QUALIFICATIONS • Board certified or board eligible in Oncology, Hematology/Oncology, or related specialty. • Experience supporting oncology clinical trials. • Understanding of late-stage clinical development, evidence generation, and the oncology treatment landscape. • Ability to interpret complex clinical data and translate findings into strategic insights. • Experience utilizing digital, analytical, or AI-enabled tools to support decision making and drive efficiency. • Demonstrated ability to work effectively across matrixed organizations and influence without authority.

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact. Relocation support available

Work Location Assignment: Hybrid 
The annual base salary for this position ranges from $239,900.00 to $399,800.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 25.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa

Similar jobs

• Medical Director/Senior Medical Director, Early Development Oncology — Johnson & Johnson · Spring House, Pennsylvania, United States
• Medical Director, Oncology (Genitourinary Focus) — Natera · Remote
• Medical Director, Oncology Clinical Development - Lung & Head/Neck Cancers — GSK · Remote
• Medical Director, Clinical Product — Cloverhealth · Remote
• Medical Director, Oncology Clinical Development - Hematology — GSK · Remote
• Executive Medical Director, Clinical Development- Immunology — Vertex · Boston, MA
• Medical Director, Gastroenterology Therapeutic Area, US Medical Affairs — Johnson & Johnson · Horsham, Pennsylvania, United States
• Global Medical Director, Oncology — GSK · Upper Providence, Pennsylvania, United States | Philadelphia, Pennsylvania, United States | London, UK